{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T12:22:00Z","timestamp":1793449320850,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Anna M\u00fcller-Grocholski Foundation"},{"DOI":"10.13039\/501100021087","name":"Albert Bruppacher Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021087","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Doc Ophthalmol"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a rare autoimmune disease affecting the central nervous system, frequently manifesting with optic neuritis (ON). Despite often favourable functional visual recovery, structural retinal changes may persist. This prospective study assessed the utility of functional and structural visual outcome measures in paediatric MOGAD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Children with serologically confirmed MOGAD were recruited from across Switzerland, alongside age-matched healthy controls. All participants underwent pattern-reversal visual evoked potentials (VEP; 15\u2032 and 60\u2032 check sizes), spectral-domain optical coherence tomography (OCT), high- and low-contrast distance visual acuity (VA), near VA, and colour vision testing. VEP outcomes were P100 peak times, and OCT outcomes were peripapillary retinal nerve fibre layer (pRNFL) thickness (global, temporal, nasal, and papillomacular bundle (PMB)), macular volume, and central retinal thickness. Discriminative performance was assessed using receiver operating characteristic (ROC) analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Twelve paediatric MOGAD patients (10.9\u2009\u00b1\u20093.1\u00a0years) and twelve age-matched controls (11.5\u2009\u00b1\u20092.8\u00a0years) were included. VEP P100 peak times were generally comparable between patients and controls. pRNFL thickness appeared lower in patients than controls. ROC analysis showed excellent to outstanding discrimination for global, PMB, temporal, and nasal pRNFL sectors, both overall and in ON+\u2009and ON\u2013 subgroups. VEP P100 peak times exhibited fair or poor discrimination overall, however 15\u2032 check sizes showed excellent discrimination between ON+\u2009and control eyes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In our cohort, OCT-derived pRNFL thickness differentiated MOGAD from controls with high accuracy, including in eyes without prior ON. VEPs showed limited utility, supporting OCT as a more sensitive marker of subclinical structural involvement.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10633-026-10082-1","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T01:44:40Z","timestamp":1771465480000},"page":"171-184","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Functional and structural outcomes in paediatric myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): a prospective study"],"prefix":"10.1007","volume":"152","author":[{"given":"Flavia C.","family":"Gericke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James V. M.","family":"Hanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Hackenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Gerth-Kahlert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,19]]},"reference":[{"issue":"1","key":"10082_CR1","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ncl.2023.06.009","volume":"42","author":"L Cacciaguerra","year":"2024","unstructured":"Cacciaguerra L, Flanagan EP (2024) Updates in NMOSD and MOGAD diagnosis and treatment: a tale of two central nervous system autoimmune inflammatory disorders. Neurol Clin 42(1):77\u2013114. https:\/\/doi.org\/10.1016\/j.ncl.2023.06.009","journal-title":"Neurol Clin"},{"issue":"9","key":"10082_CR2","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/s1474-4422(21)00218-0","volume":"20","author":"R Marignier","year":"2021","unstructured":"Marignier R, Hacohen Y, Cobo-Calvo A, Pr\u00f6bstel AK, Aktas O, Alexopoulos H et al (2021) Myelin-oligodendrocyte glycoprotein antibody-associated disease. Lancet Neurol 20(9):762\u2013772. https:\/\/doi.org\/10.1016\/s1474-4422(21)00218-0","journal-title":"Lancet Neurol"},{"issue":"12","key":"10082_CR3","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1038\/s41433-024-03108-y","volume":"38","author":"N Jeyakumar","year":"2024","unstructured":"Jeyakumar N, Lerch M, Dale RC, Ramanathan S (2024) MOG antibody-associated optic neuritis. Eye (Lond) 38(12):2289\u20132301. https:\/\/doi.org\/10.1038\/s41433-024-03108-y","journal-title":"Eye (Lond)"},{"key":"10082_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1260358","volume":"14","author":"JY Hor","year":"2023","unstructured":"Hor JY, Fujihara K (2023) Epidemiology of myelin oligodendrocyte glycoprotein antibody-associated disease: a review of prevalence and incidence worldwide. Front Neurol 14:1260358. https:\/\/doi.org\/10.3389\/fneur.2023.1260358","journal-title":"Front Neurol"},{"issue":"8","key":"10082_CR5","doi-asserted-by":"publisher","first-page":"4132","DOI":"10.1007\/s00415-023-11737-8","volume":"270","author":"A Al-Ani","year":"2023","unstructured":"Al-Ani A, Chen JJ, Costello F (2023) Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): current understanding and challenges. J Neurol 270(8):4132\u20134150. https:\/\/doi.org\/10.1007\/s00415-023-11737-8","journal-title":"J Neurol"},{"issue":"5","key":"10082_CR6","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1002\/acn3.51759","volume":"10","author":"JD Santoro","year":"2023","unstructured":"Santoro JD, Beukelman T, Hemingway C, Hokkanen SRK, Tennigkeit F, Chitnis T (2023) Attack phenotypes and disease course in pediatric MOGAD. Ann Clin Transl Neurol 10(5):672\u2013685. https:\/\/doi.org\/10.1002\/acn3.51759","journal-title":"Ann Clin Transl Neurol"},{"issue":"1","key":"10082_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-021-02160-9","volume":"18","author":"J Havla","year":"2021","unstructured":"Havla J, Pakeerathan T, Schwake C, Bennett JL, Kleiter I, Felipe-Ruci\u00e1n A et al (2021) Age-dependent favorable visual recovery despite significant retinal atrophy in pediatric MOGAD: how much retina do you really need to see well? J Neuroinflammation 18(1):121. https:\/\/doi.org\/10.1186\/s12974-021-02160-9","journal-title":"J Neuroinflammation"},{"key":"10082_CR8","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ejpn.2020.10.007","volume":"29","author":"AL Bruijstens","year":"2020","unstructured":"Bruijstens AL, Breu M, Wendel EM, Wassmer E, Lim M, Neuteboom RF et al (2020) EU paediatric MOG consortium consensus: Part 4 - Outcome of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders. Eur J Paediatr Neurol 29:32\u201340. https:\/\/doi.org\/10.1016\/j.ejpn.2020.10.007","journal-title":"Eur J Paediatr Neurol"},{"key":"10082_CR9","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ejpn.2020.04.002","volume":"27","author":"EM Wendel","year":"2020","unstructured":"Wendel EM, Baumann M, Barisic N, Blaschek A, de Coelho Oliveira Koch E, Della Marina A et al (2020) High association of MOG-IgG antibodies in children with bilateral optic neuritis. Eur J Paediatr Neurol 27:86\u201393. https:\/\/doi.org\/10.1016\/j.ejpn.2020.04.002","journal-title":"Eur J Paediatr Neurol"},{"key":"10082_CR10","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.msard.2018.11.026","volume":"28","author":"RN Narayan","year":"2019","unstructured":"Narayan RN, McCreary M, Conger D, Wang C, Greenberg BM (2019) Unique characteristics of optical coherence tomography (OCT) results and visual acuity testing in myelin oligodendrocyte glycoprotein (MOG) antibody positive pediatric patients. Mult Scler Relat Disord 28:86\u201390. https:\/\/doi.org\/10.1016\/j.msard.2018.11.026","journal-title":"Mult Scler Relat Disord"},{"key":"10082_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1137998","volume":"14","author":"O Corbali","year":"2023","unstructured":"Corbali O, Chitnis T (2023) Pathophysiology of myelin oligodendrocyte glycoprotein antibody disease. Front Neurol 14:1137998. https:\/\/doi.org\/10.3389\/fneur.2023.1137998","journal-title":"Front Neurol"},{"key":"10082_CR12","doi-asserted-by":"publisher","DOI":"10.1212\/nxi.0000000000200035","author":"EM Wendel","year":"2022","unstructured":"Wendel EM, Thonke HS, Bertolini A, Baumann M, Blaschek A, Merkenschlager A et al (2022) Temporal dynamics of MOG antibodies in children with acquired demyelinating syndrome. Neurol Neuroimmunol Neuroinflamm. https:\/\/doi.org\/10.1212\/nxi.0000000000200035","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"1","key":"10082_CR13","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/ana.25909","volume":"89","author":"A Cobo-Calvo","year":"2021","unstructured":"Cobo-Calvo A, Ruiz A, Rollot F, Arrambide G, Deschamps R, Maillart E et al (2021) Clinical features and risk of relapse in children and adults with myelin oligodendrocyte glycoprotein antibody-associated disease. Ann Neurol 89(1):30\u201341. https:\/\/doi.org\/10.1002\/ana.25909","journal-title":"Ann Neurol"},{"issue":"11","key":"10082_CR14","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1055\/a-1928-5117","volume":"239","author":"TY Lin","year":"2022","unstructured":"Lin TY, Asseyer S, Buenrostro GS, Feldmann K, Hamann S, Paul F et al (2022) Neuro-ophthalmological presentation of optic neuritis in myelin oligodendrocyte glycoprotein antibody-associated disease. Klin Monatsbl Augenheilkd 239(11):1305\u20131314. https:\/\/doi.org\/10.1055\/a-1928-5117","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"10082_CR15","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.ejpn.2020.10.006","volume":"29","author":"AL Bruijstens","year":"2020","unstructured":"Bruijstens AL, Lechner C, Flet-Berliac L, Deiva K, Neuteboom RF, Hemingway C et al (2020) E.U. paediatric MOG consortium consensus: Part 1 - Classification of clinical phenotypes of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders. Eur J Paediatr Neurol 29:2\u201313. https:\/\/doi.org\/10.1016\/j.ejpn.2020.10.006","journal-title":"Eur J Paediatr Neurol"},{"issue":"3","key":"10082_CR16","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/s1474-4422(22)00431-8","volume":"22","author":"B Banwell","year":"2023","unstructured":"Banwell B, Bennett JL, Marignier R, Kim HJ, Brilot F, Flanagan EP et al (2023) Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: international MOGAD panel proposed criteria. Lancet Neurol 22(3):268\u2013282. https:\/\/doi.org\/10.1016\/s1474-4422(22)00431-8","journal-title":"Lancet Neurol"},{"issue":"1","key":"10082_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2024.103693","volume":"24","author":"BP Trewin","year":"2025","unstructured":"Trewin BP, Brilot F, Reddel SW, Dale RC, Ramanathan S (2025) MOGAD: a comprehensive review of clinicoradiological features, therapy and outcomes in 4699 patients globally. Autoimmun Rev 24(1):103693. https:\/\/doi.org\/10.1016\/j.autrev.2024.103693","journal-title":"Autoimmun Rev"},{"issue":"12","key":"10082_CR18","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1111\/dmcn.13757","volume":"60","author":"M Eyre","year":"2018","unstructured":"Eyre M, Hameed A, Wright S, Brownlee W, Ciccarelli O, Bowman R et al (2018) Retinal nerve fibre layer thinning is associated with worse visual outcome after optic neuritis in children with a relapsing demyelinating syndrome. Dev Med Child Neurol 60(12):1244\u20131250. https:\/\/doi.org\/10.1111\/dmcn.13757","journal-title":"Dev Med Child Neurol"},{"issue":"1","key":"10082_CR19","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1177\/0883073819877334","volume":"35","author":"S Jonzzon","year":"2020","unstructured":"Jonzzon S, Suleiman L, Yousef A, Young B, Hart J, Peschl P et al (2020) Clinical features and outcomes of pediatric monophasic and recurrent idiopathic optic neuritis. J Child Neurol 35(1):77\u201383. https:\/\/doi.org\/10.1177\/0883073819877334","journal-title":"J Child Neurol"},{"key":"10082_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2022.103525","volume":"58","author":"JJ Chen","year":"2022","unstructured":"Chen JJ, Sotirchos ES, Henderson AD, Vasileiou ES, Flanagan EP, Bhatti MT et al (2022) OCT retinal nerve fiber layer thickness differentiates acute optic neuritis from MOG antibody-associated disease and Multiple Sclerosis: RNFL thickening in acute optic neuritis from MOGAD vs MS. Mult Scler Relat Disord 58:103525. https:\/\/doi.org\/10.1016\/j.msard.2022.103525","journal-title":"Mult Scler Relat Disord"},{"issue":"9","key":"10082_CR21","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1038\/s41433-021-01614-x","volume":"35","author":"OR Marmoy","year":"2021","unstructured":"Marmoy OR, Viswanathan S (2021) Clinical electrophysiology of the optic nerve and retinal ganglion cells. Eye (Lond) 35(9):2386\u20132405. https:\/\/doi.org\/10.1038\/s41433-021-01614-x","journal-title":"Eye (Lond)"},{"issue":"1","key":"10082_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10633-016-9553-y","volume":"133","author":"JV Odom","year":"2016","unstructured":"Odom JV, Bach M, Brigell M, Holder GE, McCulloch DL, Mizota A et al (2016) ISCEV standard for clinical visual evoked potentials: (2016 update). Doc Ophthalmol 133(1):1\u20139. https:\/\/doi.org\/10.1007\/s10633-016-9553-y","journal-title":"Doc Ophthalmol"},{"issue":"3","key":"10082_CR23","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s10633-017-9589-7","volume":"134","author":"M Jan\u00e1ky","year":"2017","unstructured":"Jan\u00e1ky M, J\u00e1nossy \u00c1, Horv\u00e1th G, Benedek G, Braunitzer G (2017) VEP and PERG in patients with multiple sclerosis, with and without a history of optic neuritis. Doc Ophthalmol 134(3):185\u2013193. https:\/\/doi.org\/10.1007\/s10633-017-9589-7","journal-title":"Doc Ophthalmol"},{"issue":"3","key":"10082_CR24","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1023\/b:doop.0000005335.28820.05","volume":"107","author":"M Tekavcic-Pompe","year":"2003","unstructured":"Tekavcic-Pompe M, Stirn-Kranjc B, Brecelj J (2003) Optic neuritis in children--clinical and electrophysiological follow-up. Doc Ophthalmol 107(3):261\u2013270. https:\/\/doi.org\/10.1023\/b:doop.0000005335.28820.05","journal-title":"Doc Ophthalmol"},{"issue":"9","key":"10082_CR25","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/s1474-4422(10)70168-x","volume":"9","author":"A Petzold","year":"2010","unstructured":"Petzold A, de Boer JF, Schippling S, Vermersch P, Kardon R, Green A et al (2010) Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis. Lancet Neurol 9(9):921\u2013932. https:\/\/doi.org\/10.1016\/s1474-4422(10)70168-x","journal-title":"Lancet Neurol"},{"issue":"2","key":"10082_CR26","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1177\/1352458514538110","volume":"21","author":"S Schippling","year":"2015","unstructured":"Schippling S, Balk LJ, Costello F, Albrecht P, Balcer L, Calabresi PA et al (2015) Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria. Mult Scler 21(2):163\u2013170. https:\/\/doi.org\/10.1177\/1352458514538110","journal-title":"Mult Scler"},{"issue":"3","key":"10082_CR27","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1002\/ana.26440","volume":"92","author":"FC Oertel","year":"2022","unstructured":"Oertel FC, Sotirchos ES, Zimmermann HG, Motamedi S, Specovius S, Asseyer ES et al (2022) Longitudinal retinal changes in MOGAD. Ann Neurol 92(3):476\u2013485. https:\/\/doi.org\/10.1002\/ana.26440","journal-title":"Ann Neurol"},{"issue":"6","key":"10082_CR28","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1067\/mpa.2000.110335","volume":"4","author":"RH Shute","year":"2000","unstructured":"Shute RH, Westall CA (2000) Use of the Mollon-Reffin minimalist color vision test with young children. J Am Assoc Pediatr Ophthalmol Strabismus 4(6):366\u2013372. https:\/\/doi.org\/10.1067\/mpa.2000.110335","journal-title":"J Am Assoc Pediatr Ophthalmol Strabismus"},{"issue":"1","key":"10082_CR29","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1148\/radiology.143.1.7063747","volume":"143","author":"JA Hanley","year":"1982","unstructured":"Hanley JA, McNeil BJ (1982) The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143(1):29\u201336. https:\/\/doi.org\/10.1148\/radiology.143.1.7063747","journal-title":"Radiology"},{"key":"10082_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/0471722146","volume-title":"Applied Logistic Regression","author":"DW Hosmer","year":"2000","unstructured":"Hosmer DW, Lemeshow S (2000) Applied Logistic Regression, 2nd edn. John Wiley & Sons, New York","edition":"2"},{"issue":"6","key":"10082_CR31","doi-asserted-by":"publisher","DOI":"10.1212\/nxi.0000000000200291","volume":"11","author":"G Volpe","year":"2024","unstructured":"Volpe G, Jurkute N, Girafa G, Zimmermann HG, Motamedi S, Bereuter C et al (2024) Diagnostic value of inter-eye difference metrics on OCT for myelin oligodendrocyte glycoprotein antibody-associated optic neuritis. Neurol Neuroimmunol Neuroinflamm 11(6):e200291. https:\/\/doi.org\/10.1212\/nxi.0000000000200291","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"11","key":"10082_CR32","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1177\/1352458519864928","volume":"26","author":"ES Sotirchos","year":"2020","unstructured":"Sotirchos ES, Filippatou A, Fitzgerald KC, Salama S, Pardo S, Wang J et al (2020) Aquaporin-4 IgG seropositivity is associated with worse visual outcomes after optic neuritis than MOG-IgG seropositivity and multiple sclerosis, independent of macular ganglion cell layer thinning. Mult Scler 26(11):1360\u20131371. https:\/\/doi.org\/10.1177\/1352458519864928","journal-title":"Mult Scler"},{"key":"10082_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2025.106408","volume":"98","author":"C Yano","year":"2025","unstructured":"Yano C, Matsuura E, Nakamura T, Sonoda A, Shigehisa A, Ando M et al (2025) Visual evoked potential in myelin oligodendrocyte glycoprotein antibody-associated disease. Mult Scler Relat Disord 98:106408. https:\/\/doi.org\/10.1016\/j.msard.2025.106408","journal-title":"Mult Scler Relat Disord"},{"issue":"12","key":"10082_CR34","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1002\/acn3.51473","volume":"8","author":"F Paul","year":"2021","unstructured":"Paul F, Calabresi PA, Barkhof F, Green AJ, Kardon R, Sastre-Garriga J et al (2021) Optical coherence tomography in multiple sclerosis: a 3-year prospective multicenter study. Ann Clin Transl Neurol 8(12):2235\u20132251. https:\/\/doi.org\/10.1002\/acn3.51473","journal-title":"Ann Clin Transl Neurol"},{"issue":"4","key":"10082_CR35","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1136\/jnnp-2014-308189","volume":"86","author":"LJ Balk","year":"2015","unstructured":"Balk LJ, Steenwijk MD, Tewarie P, Daams M, Killestein J, Wattjes MP et al (2015) Bidirectional trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis. J Neurol Neurosurg Psychiatry 86(4):419\u2013424. https:\/\/doi.org\/10.1136\/jnnp-2014-308189","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10082_CR36","doi-asserted-by":"publisher","DOI":"10.1212\/nxi.0000000000000671","author":"CA Wicki","year":"2020","unstructured":"Wicki CA, Manogaran P, Simic T, Hanson JVM, Schippling S (2020) Bilateral retinal pathology following a first-ever clinical episode of autoimmune optic neuritis. Neurol Neuroimmunol Neuroinflamm. https:\/\/doi.org\/10.1212\/nxi.0000000000000671","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10082_CR37","doi-asserted-by":"publisher","DOI":"10.1212\/nxi.0000000000000805","author":"S Motamedi","year":"2020","unstructured":"Motamedi S, Oertel FC, Yadav SK, Kadas EM, Weise M, Havla J et al (2020) Altered fovea in AQP4-IgG-seropositive neuromyelitis optica spectrum disorders. Neurol Neuroimmunol Neuroinflamm. https:\/\/doi.org\/10.1212\/nxi.0000000000000805","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"1","key":"10082_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-19848-4","volume":"12","author":"NK Gigengack","year":"2022","unstructured":"Gigengack NK, Oertel FC, Motamedi S, Bereuter C, Duchow A, Rust R et al (2022) Structure-function correlates of vision loss in neuromyelitis optica spectrum disorders. Sci Rep 12(1):17545. https:\/\/doi.org\/10.1038\/s41598-022-19848-4","journal-title":"Sci Rep"},{"issue":"1","key":"10082_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-46251-3","volume":"9","author":"M Vabanesi","year":"2019","unstructured":"Vabanesi M, Pisa M, Guerrieri S, Moiola L, Radaelli M, Medaglini S et al (2019) In vivo structural and functional assessment of optic nerve damage in neuromyelitis optica spectrum disorders and multiple sclerosis. Sci Rep 9(1):10371. https:\/\/doi.org\/10.1038\/s41598-019-46251-3","journal-title":"Sci Rep"},{"issue":"10","key":"10082_CR40","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/s41582-024-01005-2","volume":"20","author":"R Geraldes","year":"2024","unstructured":"Geraldes R, Arrambide G, Banwell B, Rovira \u00c0, Cortese R, Lassmann H et al (2024) The influence of MOGAD on diagnosis of multiple sclerosis using MRI. Nat Rev Neurol 20(10):620\u2013635. https:\/\/doi.org\/10.1038\/s41582-024-01005-2","journal-title":"Nat Rev Neurol"},{"issue":"10","key":"10082_CR41","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.28871","volume":"4","author":"G Fadda","year":"2021","unstructured":"Fadda G, Alves CA, O\u2019Mahony J, Castro DA, Yeh EA, Marrie RA et al (2021) Comparison of spinal cord magnetic resonance imaging features among children with acquired demyelinating syndromes. JAMA Netw Open 4(10):e2128871. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.28871","journal-title":"JAMA Netw Open"},{"issue":"12","key":"10082_CR42","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.37833","volume":"4","author":"V Camera","year":"2021","unstructured":"Camera V, Holm-Mercer L, Ali AAH, Messina S, Horvat T, Kuker W et al (2021) Frequency of new silent MRI lesions in myelin oligodendrocyte glycoprotein antibody disease and aquaporin-4 antibody neuromyelitis optica spectrum disorder. JAMA Netw Open 4(12):e2137833. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.37833","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10082_CR43","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1148\/radiol.2291010898","volume":"229","author":"NA Obuchowski","year":"2003","unstructured":"Obuchowski NA (2003) Receiver operating characteristic curves and their use in radiology. Radiology 229(1):3\u20138. https:\/\/doi.org\/10.1148\/radiol.2291010898","journal-title":"Radiology"},{"issue":"1","key":"10082_CR44","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ajo.2010.06.041","volume":"151","author":"MT Leite","year":"2011","unstructured":"Leite MT, Rao HL, Weinreb RN, Zangwill LM, Bowd C, Sample PA et al (2011) Agreement among spectral-domain optical coherence tomography instruments for assessing retinal nerve fiber layer thickness. Am J Ophthalmol 151(1):85-92.e1. https:\/\/doi.org\/10.1016\/j.ajo.2010.06.041","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10082_CR45","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s10633-025-10042-1","volume":"151","author":"M \u0160u\u0161tar Habjan","year":"2025","unstructured":"\u0160u\u0161tar Habjan M, Bach M, van Genderen MM, Li S, Mizota A, Nilsson J et al (2025) ISCEV standard for clinical visual evoked potentials (2025 update). Doc Ophthalmol 151(2):97\u2013112. https:\/\/doi.org\/10.1007\/s10633-025-10042-1","journal-title":"Doc Ophthalmol"},{"issue":"2","key":"10082_CR46","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s10633-025-10012-7","volume":"150","author":"DA Thompson","year":"2025","unstructured":"Thompson DA, Marmoy OR, Cowe J, Handley SE (2025) Multi-channel pattern veps with full and half field stimulation: methods of interpretation and diagnostic evaluation. Doc Ophthalmol 150(2):87\u201395. https:\/\/doi.org\/10.1007\/s10633-025-10012-7","journal-title":"Doc Ophthalmol"},{"issue":"9","key":"10082_CR47","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1038\/s41433-021-01680-1","volume":"35","author":"SE Handley","year":"2021","unstructured":"Handley SE, \u0160u\u0161tar M, Tekav\u010di\u010d Pompe M (2021) What can visual electrophysiology tell about possible visual-field defects in paediatric patients. Eye (Lond) 35(9):2354\u20132373. https:\/\/doi.org\/10.1038\/s41433-021-01680-1","journal-title":"Eye (Lond)"}],"container-title":["Documenta Ophthalmologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10633-026-10082-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10633-026-10082-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10633-026-10082-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T14:09:18Z","timestamp":1791986958000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10633-026-10082-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,19]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10082"],"URL":"https:\/\/doi.org\/10.1007\/s10633-026-10082-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7977410\/v1","asserted-by":"object"}]},"ISSN":["0012-4486","1573-2622"],"issn-type":[{"value":"0012-4486","type":"print"},{"value":"1573-2622","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,19]]},"assertion":[{"value":"29 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article was originally published under the subscription model but it is now published under an Open Access license.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no potential conflicts of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study adhered to the tenets of the Declaration of Helsinki. Ethical approval was obtained from the Cantonal Ethics Committee of Zurich. Written informed consent was provided by the parents\/guardians of all participants. No animals were used during the course of the study.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}